Key result
Transcriptomic marker LYVE1 correlates strongly with MELD-XI, while TIMP4 and CDK1 track RV severity and mortality.
Why the study?
Clinical stratification in heart failure has historically relied on hemodynamic parameters while often overlooking the distinct molecular profile of the right ventricle.
Do transcriptomic signatures in heart tissue and peripheral blood mononuclear cells correlate with right ventricular dysfunction, systemic complications, and 1-year mortality in patients with advanced heart failure?
Observational (n=138)
Do transcriptomic signatures in heart tissue and peripheral blood mononuclear cells correlate with right ventricular dysfunction, systemic complications, and 1-year mortality in patients with advanced heart failure?
Transcriptomic signatures in heart tissue and PBMCs correlate with right ventricular dysfunction, hepatic congestion, and 1-year mortality, offering a molecular framework to stratify systemic complications in advanced heart failure.
Answers are grounded in this paper and cite their sources.
May support molecular risk stratification in advanced HF; leaves open whether transcriptomic signatures improve outcomes over clinical scores.
Background: Heart failure (HF) is a complex syndrome where clinical stratification has historically relied on hemodynamic parameters, often overlooking the distinct molecular profile of the Right Ventricle (RV). Methods: This study used a multi-stage design, interrogating 109 human heart tissue samples (CAGE-seq) and validating findings in 29 Peripheral Blood Mononuclear Cell (PBMC) profiles from patients undergoing Mechanical Circulatory Support (MCS). Results: We identified robust correlations between gene expression and clinical phenotypes. Specifically, the lymphatic marker LYVE1 showed a strong positive correlation with the MELD-XI score (r=0.64, p<0.01) and the SOFA score (r=0.39, p=0.041), linking lymphatic activation to congestive hepatopathy. In the RV, TIMP4 expression was significantly higher in patients with moderate-to-severe dysfunction compared to mild cases (ANOVA p=0.041), also correlating with RV dimensions (r=0.40, p<0.05)4. A collagen switch was observed where COL21A1 correlated with adverse outcomes (r=0.26) while COL24A1 was protective. Furthermore, in patients with preserved RV function, elevated CDK1 was a significant predictor of 1-year mortality (p=0.024), serving as a hidden signal of cellular failure. Finally, IL12A showed significant upregulation in females compared to males (p=0.035), suggesting sex-specific inflammatory pathways. Conclusions: These findings offer a biologically relevant framework for monitoring and treating the systemic complications of HF which may be stratified at a molecular level.
No takes yet. Share an insight, caveat, or question.
Zainab M. Lateef (2026) conducted an observational in Advanced heart failure and right ventricular dysfunction (n=138). Transcriptomic gene expression signatures (LYVE1, TIMP4, COL21A1, COL24A1, CDK1, IL12A) was evaluated on Correlation between transcriptomic gene expression signatures and clinical phenotypes (MELD-XI score, SOFA score, right ventricular dysfunction/dimensions, and 1-year mortality) (r=0.64, p=<0.01). LYVE1 expression strongly correlated with MELD-XI, TIMP4 increased in moderate-to-severe RV dysfunction, and elevated CDK1 predicted 1-year mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: